Improved asymmetry prediction for short interfering RNAs

FEBS Journal

Volumn 281, Issue 1, 2014, Pages 320-330

  Malefyt, Amanda P ^a,c   Wu, Ming ^a,d   Vocelle, Daniel B ^a   Kappes, Sean J ^a   Lindeman, Stephen D ^a   Chan, Christina ^a,b   Walton, S Patrick ^a  

^a Michigan State University   (United States)

^b Michigan State University   (United States)

^c The University of Texas at Austin   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

asymmetry; dsRNA dependent protein kinase R; enhanced green fluorescent protein; short interfering RNA

Indexed keywords

MESSENGER RNA; PROTEIN KINASE R; SMALL INTERFERING RNA;

ARTICLE; CARCINOMA CELL; GENE SEQUENCE; GENE SILENCING; GENETIC ALGORITHM; HUMAN; LUNG CARCINOMA; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RNA HYBRIDIZATION; RNA INTERFERENCE; RNA STABILITY; SEQUENCE ALIGNMENT; THERMODYNAMICS; THERMOSTABILITY;

EID: 84891778982     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12599     Document Type: Article

References (53)

1. Fire A, Xu S, Montgomery M, Kostas S, Driver S, &, Mello C, (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811.
2. Matranga C, Tomari Y, Shin C, Bartel DP, &, Zamore PD, (2005) Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell 123, 607-620.
3. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, &, Tuschl T, (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
4. Pollack A, (2011) Drugmakers' fever for the power of RNA interference has cooled. New York Times.
5. Krieg AM, (2011) Is RNAi dead? Mol Ther 19, 1001-1002.
6. Gitig D, (2012) Use of siRNA in therapeutic arena on the upswing. Genet Eng Biotech News, 12, 24-26.
7. Davidson BL, &, McCray PB, (2011) Current prospects for RNA interference-based therapies. Nat Rev Genet 12, 329-340.
8. Angart P, Vocelle D, Chan C, &, Walton SP, (2013) Design of siRNA therapeutics from the molecular scale. Pharmaceuticals 6, 440-468.
9. Portis AM, Carballo G, Baker GL, Chan C, &, Walton SP, (2010) Confocal microscopy for the analysis of siRNA delivery by polymeric nanoparticles. Microsc Res Tech 73, 878-885.
10. Lu JJ, Langer R, &, Chen JZ, (2009) A novel mechanism is involved in cationic lipid-mediated functional siRNA delivery. Mol Pharmaceut 6, 763-771.
11. Siegwart DJ, Whitehead KA, Nuhn L, Sahay G, Cheng H, Jiang S, Ma M, Lytton-Jean A, Vegas A, Fenton P, et al,. (2011) Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery. Proc Natl Acad Sci USA 108, 12996-13001.
12. Ameres SL, Martinez J, &, Schroeder R, (2007) Molecular basis for target RNA recognition and cleavage by human RISC. Cell 130, 101-112.
13. Brown KM, Chu C-Y, &, Rana TM, (2005) Target accessibility dictates the potency of human RISC. Nat Struct Mol Biol 12, 469-470.
14. Gredell JA, Berger AK, &, Walton SP, (2008) Impact of target mRNA structure on siRNA silencing efficiency: A large-scale study. Biotechnol Bioeng 100, 744-755.
15. Kiryu H, Terai G, Imamura O, Yoneyama H, Suzuki K, &, Asai K, (2011) A detailed investigation of accessibilities around target sites of siRNAs and miRNAs. Bioinformatics 27, 1788-1797.
16. MacRae IJ, Ma E, Zhou M, Robinson CV, &, Doudna JA, (2007) In vitro reconstitution of the human RISC-loading complex. Proc Natl Acad Sci USA 105, 512-517.
17. Maniataki E, &, Mourelatos Z, (2005) A human, ATP-independent, RISC assembly machine fueled by pre-miRNA. Genes Dev 19, 2979-2990.
18. Gredell JA, Dittmer MJ, Wu M, Chan C, &, Walton SP, (2010) Recognition of siRNA asymmetry by TAR RNA binding protein. Biochemistry 49, 3148-3155.
19. Kini HK, &, Walton SP, (2009) Effect of siRNA terminal mismatches on TRBP and Dicer binding and silencing efficacy. FEBS J 276, 6576-6585.
20. Rivas FV, Tolia NH, Song JJ, Aragon JP, Liu JD, Hannon GJ, &, Joshua-Tor L, (2005) Purified Argonaute2 and an siRNA form recombinant human RISC. Nat Struct Mol Biol 12, 340-349.
21. Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K, &, Shiekhattar R, (2005) TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436, 740-744.
22. Haase AD, Jaskiewicz L, Zhang H, Laine S, Sack R, Gatignol A, &, Filipowicz W, (2005) TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing. EMBO Rep 6, 961-967.
23. Lima WF, Murray H, Nichols JG, Wu H, Sun H, Prakash TP, Berdeja AR, Gaus HJ, &, Crooke ST, (2009) Human Dicer binds short single-strand and double-strand RNA with high affinity and interacts with different regions of the nucleic acids. J Biol Chem 284, 2535-2548.
24. Kok KH, Ng MHJ, Ching YP, &, Jin DY, (2007) Human TRBP and PACT directly interact with each other and associate with dicer to facilitate the production of small interfering RNA. J Biol Chem 282, 17649-17657.
25. Lee Y, Hur I, Park SY, Kim YK, Suh MR, &, Kim VN, (2006) The role of PACT in the RNA silencing pathway. EMBO J 25, 522-532.
26. Ye X, Huang N, Liu Y, Paroo Z, Huerta C, Li P, Chen S, Liu Q, &, Zhang H, (2011) Structure of C3PO and mechanism of human RISC activation. Nat Struct Mol Biol 18, 650-657.
27. Tomari Y, Matranga C, Haley B, Martinez N, &, Zamore PD, (2004) A protein sensor for siRNA asymmetry. Science 306, 1377-1380.
28. Leuschner PJF, Ameres SL, Kueng S, &, Martinez J, (2006) Cleavage of the siRNA passenger strand during RISC assembly in human cells. EMBO Rep 7, 314-320.
29. Schwarz D, Hutvagner G, Du T, Xu Z, Aronin N, &, Zamore P, (2003) Asymmetry in the assembly of the RNAi enzyme complex. Cell 115, 199-208.
30. Frank F, Sonenberg N, &, Nagar B, (2010) Structural basis for 5′-nucleotide base-specific recognition of guide RNA by human AGO2. Nature 465, 818-822.
31. Noland CL, Ma E, &, Doudna JA, (2011) siRNA repositioning for guide strand selection by human dicer complexes. Mol Cell 43, 110-121.
32. Betancur JG, &, Tomari Y, (2012) Dicer is dispensable for asymmetric RISC loading in mammals. RNA 18, 24-30.
33. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, &, Khvorova A, (2004) Rational siRNA design for RNA interference. Nat Biotechnol 22, 326-330.
34. Amarzguioui M, &, Prydz H, (2004) An algorithm for selection of functional siRNA sequences. Biochem Biophys Res Commun 316, 1050-1058.
35. Ui-Tei K, Naito Y, Takahashi F, Haraguchi T, Ohki-Hamazaki H, Juni A, Ueda R, &, Saigo K, (2004) Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res 32, 936-948.
36. Lu ZJ, &, Mathews DH, (2008) Efficient siRNA selection using hybridization thermodynamics. Nucleic Acids Res 36, 640-647.
37. Ichihara M, Murakumo Y, Masuda A, Matsuura T, Asai N, Jijiwa M, Shinmi J, Yatsuya H, Qiao S, Takahashi M, et al,. (2007) Thermodynamic instability of siRNA duplex is a prerequisite for dependable prediction of siRNA activites. Nucleic Acids Res 35, e123.
38. Walton SP, Wu M, Gredell JA, &, Chan C, (2010) Designing highly active siRNAs for therapeutic applications. FEBS J 277, 4806-4813.
39. Yang X, &, Chan C, (2009) Repression of PKR mediates palmitate-induced apoptosis in HepG2 cells through regulation of Bcl-2. Cell Res 19, 469-486.
40. Laraki G, Clerzius G, Daher A, Melendez-Pena C, Daniels S, &, Gatignol A, (2008) Interactions between the double-stranded RNA-binding proteins TRBP and PACT define the Medipal domain that mediates protein-protein interactions. RNA Biol 5, 92-103.
41. Birmingham A, Anderson E, Sullivan K, Reynolds A, Boese Q, Leake D, Karpilow J, &, Khvorova A, (2007) A protocol for designing siRNAs with high functionality and specificity. Nat Protoc 2, 2068-2078.
42. Mysara M, Garibaldi JM, &, El Hefnawi M, (2011) MysiRNA-Designer: a workflow for efficient siRNA design. PLoS ONE 6, e25642.
43. Huesken D, Lange J, Mickanin C, Weiler J, Asselbergs F, Warner J, Meloon B, Engel S, Rosenberg A, Cohen D, et al,. (2005) Design of a genome-wide siRNA library using an artificial neural network. Nat Biotechnol 23, 995-1001.
44. Shabalina SA, Spiridonov AN, &, Ogurtsov AY, (2006) Computational models with thermodynamic and composition features improve siRNA design. BMC Bioinformatics 7, 65.
45. Yuan B, Latek R, Hossbach M, Tuschl T, &, Lewitter F, (2004) siRNA selection server: an automated siRNA oligonucleotide prediction server. Nucleic Acids Res 32, W130-W134.
46. Takasaki S, (2009) Selecting effective siRNA target sequences by using Bayes' theorem. Comput Biol Chem 33, 368-372.
47. Ladunga I, (2006) More complete gene silencing by fewer siRNAs: transparent optimized design and biophysical signature. Nucleic Acids Res 35, 433-440.
48. Matveeva OV, Nechipurenko YD, Rossi L, Moore B, Saetrom P, Ogurtsov AY, Atkins JF, &, Shabalina SA, (2007) Comparison of approaches for rational siRNA design leading to a new efficient and transparent method. Nucleic Acids Res 35, e63.
49. Khvorova A, Reynolds A, &, Jayasena SD, (2003) Functional siRNAs and miRNAs exhibit strand bias. Cell 115, 209-216.
50. Overhoff M, Alken M, Far RK-K, Lemaitre M, Lebleu B, Sczakiel G, &, Robbins I, (2005) Local RNA target structure influences siRNA efficacy: a systematic global analysis. J Mol Biol 348, 871-881.
51. Shao Y, Chan CY, Maliyekkel A, Lawrence CE, Roninson IB, &, Ding Y, (2007) Effect of target secondary structure on RNAi efficiency. RNA 13, 1631-1640.
52. Seitz H, Tushir J, &, Zamore P, (2011) A 5′-uridine amplifies miRNA/miRNA* asymmetry in Drosophila by promoting RNA-induced silencing complex formation. Silence 2011, 2:4.
53. Xia T, SantaLucia J Jr, Burkard ME, Kierzek R, Schroeder SJ, Jiao X, Cox C, &, Turner DH, (1998) Thermodynamic parameters for an expanded nearest-neighbor model for formation of RNA duplexes with Watson-Crick base pairs. Biochemistry 37, 14719-14735.